Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron Feb 12, 2022 6:50pm
536 Views
Post# 34423693

RE:RE:RE:Vaccine competition?

RE:RE:RE:Vaccine competition?

Yes, I'm familiar with them.  These Aerochambers (aka spacers) are often used in pediatric asthma to help deliver at least some medication; however, these spacer can also be used improperly & a portion of the medication inevitably gets deposited on the inner walls of the chamber.  The hand-held inhaler when used correctly w/o the spacer is generally considered more effective...it's a direct shot into the upper airway.  I was referring to another form of inhalation that can provide more positive pressure to direct the medication into the airway in select circumstances.  

And there are other ways to deliver medication for ventilated or hospitalized patients requiring nebulized/inhaled treatments.  Helium-oxygen mixtures have also been shown in the inpatient setting to improve laminar flow & decrease airway resistance which could potentially improve aerosolized drug delivery.  So an inhaled therapeutic that TLT may or may not investigate could potentially have a positive impact on the entire disease spectrum.  JMO...& sorry for my rambling again.  Good luck...

<< Previous
Bullboard Posts
Next >>